5 Amino 1mq Peptide CAS 42464-96-0

Research on 5 amino 1mq peptide

Obesity is a serious and increasingly serious global health problem, and there are few effective treatment methods. The study investigated the metabolic and physiological benefits of the combination of 5-amino-1MQ treatment and dietary replacement for diet-induced obese mice. Compared with simply improving diet, 5-amino-1MQ treatment combined with dietary replacement can accelerate and improve weight and fat reduction, increase the ratio of lean body mass to body weight, reduce the weight of white adipose tissue in the liver and epididymis, reduce liver obesity, and improve liver steatosis when replaced alone. Importantly, the combination of the two can normalize body composition and liver obesity parameters. 5-amino-1MQ treatment has produced unique metabolomic characteristics in adipose tissue, mainly increasing the abundance of ketogenic amino acids and alterations in metabolites related to energy metabolism pathways. In conclusion, the regulation of body weight, obesity, liver physiology and adipose tissue metabolome by 5-amino-1MQ therapy strongly supports it as a promising treatment for obesity and obesity-induced comorbidities.
In addition, 5-amino-1MQ can also enhance strength and promote the regenerative ability of aging muscles, thereby providing a promising treatment for sarcopenia. Studies have shown that 5-amino-1MQ treatment can not only promote the quantifiable improvement of lipid content in muscle cells, but also significantly increase gastrocnemius muscle fibers when combined with exercise. Drugs based on 5 amino 1mq peptide, whether used alone or in combination with exercise, will be beneficial for the treatment of sarcopenia and various age-related myopathy.